Skip to main content

On February 13, the Centers for Disease Control and Prevention (CDC) established a new federal advisory committee to make recommendations to the Centers for Disease Control and Prevention (CDC) about reducing lead exposure and lead poisoning.

According to the official Notice of Establishment for the Lead Exposure and Prevention Advisory Committee (LEPAC) released by CDC the LEPAC will (1) Review the Federal programs and services available to individuals and communities exposed to lead; (2) review current research on lead exposure to identify additional research needs; (3) review and identify best practices, or the need for best practices regarding lead screening and the prevention of lead poisoning; (4) identify effective services, including services relating to healthcare, education, and nutrition for individuals and communities affected by lead exposure and lead poisoning, including in consultation with, as appropriate, the lead exposure registry as established in Section 2203(b) of Public Law 114-322; and (5) undertake any other review or activities that the Secretary determines to be appropriate.

A second notice soliciting nominations, posted in the Federal Register February 21, asks the public to nominate federal and non-federal experts in fields associated with lead screening, the prevention of lead exposure, and services for individuals and communities affected by lead exposure. Fifteen members will be invited to serve three-year terms to “review research and Federal programs and services related to lead poisoning and identify effective services and best practices for addressing and preventing lead exposures in communities.”